Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colm Morrissey

Showing results (91-100 of 172) with videos related to

Pageof 18
Sort By:
Nature Communications|January 31, 2015
NR2F1 controls tumour cell dormancy via SOX9- and RARβ-driven quiescence programmesMaria Soledad Sosa, Falguni Parikh, Alexandre Gaspar Maia, et al.
Cell Reports|May 28, 2020
Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication StressMichael D Nyquist, Alexandra Corella, Ilsa Coleman, et al.
Neoplasia (New York, N.Y.)|March 15, 2025
LSD1+8a is an RNA biomarker of neuroendocrine prostate cancerAnbarasu Kumaraswamy, Rahul Mannan, Olivia A Swaim, et al.
The Prostate|February 4, 2017
LuCaP Prostate Cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease an--d Serve as Models for Evaluating Cancer TherapeuticsHolly M Nguyen, Robert L Vessella, Colm Morrissey, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 12, 2026
Dynamic Shifts in ER-Plasma Membrane Junctions Signaling Define Pro-Metastatic N-Glycosylation and Predict Prostate Cancer ProgressionAmanda J Macke, Tania Kamal, Taylor E Divita, et al.
Nature Communications|September 26, 2014
Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancerColin C Pritchard, Colm Morrissey, Akash Kumar, et al.
Cancer Research|May 9, 2019
Upregulation of Scavenger Receptor B1 Is Required for Steroidogenic and Nonsteroidogenic Cholesterol Metabolism in Prostate CancerJacob A Gordon, Jake W Noble, Ankur Midha, et al.
Cell Reports|December 26, 2024
MIRO2 promotes cancer invasion and metastasis via MYO9B suppression of RhoA activityDillon P Boulton, Connor J Hughes, Valentina Vaira, et al.
The Journal of Clinical Investigation|December 5, 2018
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progressionBing Song, Su-Hong Park, Jonathan C Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 9, 2018
<i>BMI1</i> Drives Metastasis of Prostate Cancer in Caucasian and African-American Men and Is A Potential Therapeutic Target: Hypothesis Tested in Race-specific ModelsArsheed A Ganaie, Firdous H Beigh, Matteo Astone, et al.
Pageof 18

Showing results (91-100 of 172) with videos related to

Sort By:
Pageof 18
Nature Communications|January 31, 2015
NR2F1 controls tumour cell dormancy via SOX9- and RARβ-driven quiescence programmesMaria Soledad Sosa, Falguni Parikh, Alexandre Gaspar Maia, et al.
Cell Reports|May 28, 2020
Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication StressMichael D Nyquist, Alexandra Corella, Ilsa Coleman, et al.
Neoplasia (New York, N.Y.)|March 15, 2025
LSD1+8a is an RNA biomarker of neuroendocrine prostate cancerAnbarasu Kumaraswamy, Rahul Mannan, Olivia A Swaim, et al.
The Prostate|February 4, 2017
LuCaP Prostate Cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease an--d Serve as Models for Evaluating Cancer TherapeuticsHolly M Nguyen, Robert L Vessella, Colm Morrissey, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 12, 2026
Dynamic Shifts in ER-Plasma Membrane Junctions Signaling Define Pro-Metastatic N-Glycosylation and Predict Prostate Cancer ProgressionAmanda J Macke, Tania Kamal, Taylor E Divita, et al.
Nature Communications|September 26, 2014
Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancerColin C Pritchard, Colm Morrissey, Akash Kumar, et al.
Cancer Research|May 9, 2019
Upregulation of Scavenger Receptor B1 Is Required for Steroidogenic and Nonsteroidogenic Cholesterol Metabolism in Prostate CancerJacob A Gordon, Jake W Noble, Ankur Midha, et al.
Cell Reports|December 26, 2024
MIRO2 promotes cancer invasion and metastasis via MYO9B suppression of RhoA activityDillon P Boulton, Connor J Hughes, Valentina Vaira, et al.
The Journal of Clinical Investigation|December 5, 2018
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progressionBing Song, Su-Hong Park, Jonathan C Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 9, 2018
<i>BMI1</i> Drives Metastasis of Prostate Cancer in Caucasian and African-American Men and Is A Potential Therapeutic Target: Hypothesis Tested in Race-specific ModelsArsheed A Ganaie, Firdous H Beigh, Matteo Astone, et al.
Pageof 18